Bio Essence (BIOE) Return on Capital Employed (2021 - 2026)
Bio Essence (BIOE) recorded quarterly Return on Capital Employed of 84.94% in Q1 2026, down 101.56% quarter-over-quarter from 42.14% in Q4 2025, and down 10253.0% on a YoY basis from N/an in Q1 2025.
Bio Essence (BIOE) Return on Capital Employed (2021 - 2026) Analysis & Trends
Bio Essence's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 84.94% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 10253.0% year-over-year to 84.94%; the TTM figure through Mar 2026 stood at 84.94% (down 10253.0% YoY), while the FY2025 annual figure was 43.12%, down 7893.0% from the prior year.
- Return on Capital Employed was 84.94% for Q1 2026 at Bio Essence, down from 42.14% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4135.3% in Q2 2023 to a low of 84.94% in Q1 2026.
- Historically, Return on Capital Employed has averaged 308.59% across 5 years, with a median of 26.07% in 2022.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed soared 408235 bps in 2023, then slumped 407160 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 26.07% in 2022, then jumped by 2757 bps to 744.94% in 2023, then plunged by 97 bps to 19.94% in 2024, then slumped by 311 bps to 42.14% in 2025, then sank by 102 bps to 84.94% in 2026.
- The last three Return on Capital Employed figures came in at 84.94% (Q1 2026), 42.14% (Q4 2025), and 4.08% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Bio Essence | - | - | 319,353.00 | -84.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.94% |
| Dec 31, 2025 | -42.14% |
| Sep 30, 2025 | 4.08% |
| Jun 30, 2025 | 10.11% |
| Mar 31, 2025 | 17.59% |
| Dec 31, 2024 | 19.94% |
| Sep 30, 2024 | 39.66% |
| Jun 30, 2024 | 63.70% |
| Mar 31, 2024 | 114.90% |
| Dec 31, 2023 | 744.94% |
| Sep 30, 2023 | 20.45% |
| Jun 30, 2023 | 4,135.30% |
| Mar 31, 2023 | 13.80% |
| Dec 31, 2022 | 26.07% |
| Sep 30, 2022 | 45.15% |
| Jun 30, 2022 | 52.95% |
| Mar 31, 2022 | 64.53% |
| Dec 31, 2021 | 84.08% |
| Sep 30, 2021 | 104.28% |
| Jun 30, 2021 | 138.16% |